We are live on
!
Find out more
Corvus Pharmaceuticals
CRVS
CRVS
54 hedge funds and large institutions have $280M invested in Corvus Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
32% more capital invested
Capital invested by funds: $212M → $280M (+$67.9M)
19% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 16
4% more funds holding
Funds holding: 52 → 54 (+2)
0.19% more ownership
Funds ownership: 83.59% → 83.78% (+0.19%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
54
Holders Change
+2
Holders Change %
+3.85%
% of All Funds
1.35%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
6
Increased
19
Reduced
16
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$2.56M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
+$1.43M |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$1.18M |
| 4 |
Renaissance Technologies
New York
|
+$791K |
| 5 |
TI
Telemetry Investments
New York
|
+$374K |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.71M |
| 2 |
Jennison Associates
New York
|
-$1.75M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$535K |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$517K |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$501K |
